Clinical Trial Update: Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains [Phase 2]

View source ↗

Summary

A Phase 2 dose-ranging study evaluating rapamycin for port-wine stains is listed as not yet recruiting. The trial status indicates it has not begun recruiting y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Port-wine Stain

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: AFT Pharmaceuticals, Ltd. | Conditions: Port Wine Stains | Phase 2 | Status: NOT_YET_RECRUITING